<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34354381</article-id>
      <article-id pub-id-type="pmc">8331078</article-id>
      <article-id pub-id-type="publisher-id">310351</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S310351</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Roles of Exosomes and Exosomal MicroRNAs in Postoperative Sleep Disturbance</article-title>
        <alt-title alt-title-type="running-authors">Gu and Zhu</alt-title>
        <alt-title alt-title-type="running-title">Gu and Zhu</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gu</surname>
            <given-names>Xiangyi</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Junchao</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
          <xref ref-type="corresp" rid="an0001"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Anesthesiology, Shengjing Hospital of China Medical University</institution>, <addr-line>Shenyang</addr-line>, <addr-line>Liaoning</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Junchao Zhu <institution>Department of Anesthesiology, Shengjing Hospital of China Medical University</institution>, <addr-line>Shenyang</addr-line>, <addr-line>Liaoning</addr-line>, <country>People’s Republic of China</country> Email zhujunchao1@hotmail.com</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <fpage>1363</fpage>
      <lpage>1375</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>7</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2021 Gu and Zhu.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Gu and Zhu.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>Postoperative sleep disturbance (PSD) often occurs in elderly patients after major surgery and exerts harmful effects on postoperative recovery. PSD may increase the incidence of postoperative fatigue, severe anxiety and depression, pain sensitivity, and cognitive dysfunction, which can cause or aggravate neurodegenerative diseases via amyloid aggregation and tau accumulation. Exosomes are important carriers that mediate the transfer of active substances and genetic information among cells. Recent evidence has shown that exosomes are involved in the pathogenesis of end-organ morbidity caused by sleep disorders via increasing amyloid plaque formation, transmitting tau protein, regulating neuroinflammation, and increasing blood–brain barrier permeability. Additionally, exosomes may be useful for delivering therapeutic genetic materials, such as microRNAs (miRNAs) and proteins, to exert neuroprotective effects and reduce cognitive impairment. However, the molecular mechanisms underlying this process remain to be fully elucidated. This review focuses on exosome-related pathways and the modulatory role of exosomal miRNAs on the pathogenesis of sleep disturbance and neurodegeneration. Moreover, we discuss the advantages of reducing neurotoxic proteins via exosomal intervention and miRNA regulation. Future research in exosome administration may offer new insights into PSD-related pathomechanisms and therapeutics.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>postoperative sleep disturbance</kwd>
        <kwd>exosomes</kwd>
        <kwd>exosomal miRNAs</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>No funding</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <funding-statement>No funding was received for this research.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="1"/>
        <ref-count count="120"/>
        <page-count count="13"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p>Postoperative sleep disturbance (PSD) is a common complication after a major surgery,<xref rid="cit0001" ref-type="bibr">1</xref>,<xref rid="cit0002" ref-type="bibr">2</xref> with patients often presenting with reduced sleep quality and duration, early awakening, frequent nightmares, sleep terrors, and sleep-related breathing disorders.<xref rid="cit0003" ref-type="bibr">3</xref> Polysomnography studies on patients with sleep disorders have suggested occurrence of sleep fragmentation and deprivation as well as decrease in rapid eye movement (REM) and slow-wave sleep (SWS) after surgery.<xref rid="cit0004" ref-type="bibr">4</xref> Additionally, PSD seriously affects the quality of life and increases the difficulty and burden of nursing care. The onset of sleep disorders is related to multiple factors, including age, preoperative complications, type of anaesthesia, degree of surgical trauma, and postoperative pain. Moreover, studies show that sleep disorders can be related to changes in postoperative brain function and increase the risk of postoperative cognitive decline.<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0006" ref-type="bibr">6</xref> Early recognition and intervention of sleep disorders can reduce the incidence of mental dysfunction and cardiovascular events, improve prognosis, and shorten the duration of hospital stay.<xref rid="cit0007" ref-type="bibr">7</xref></p>
      <p>Exosomes are extracellular vesicles (diameter: 30–100 nm) that contain various active substances, such as proteins, small-interfering (si)RNAs, and microRNAs (miRNAs), and act as important carriers that mediate information exchange and material transfer among cells.<xref rid="cit0008" ref-type="bibr">8</xref> Regulatory molecules, such as miRNAs, are transported to recipient cells via exosomes, where they affect biological pathways, leading to changes in cell function and pathology.<xref rid="cit0009" ref-type="bibr">9</xref> Several recent studies have shown that nerve cell-derived exosomes are related to pathological protein aggregation, synaptic morphology, and neuroinflammation, and that changes in exosome biological characteristics and level of dysfunction might be involved in neurodegeneration. Goetzl et al<xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0011" ref-type="bibr">11</xref> reported that in Alzheimer’s disease (AD), P-S396-tau, P-T181-tau, and Aβ1-42 are elevated in plasma nerve cell-derived exosomes and can be used to predict the transition from preclinical AD to AD. This review summarised current perspectives regarding the role of exosomes and exosomal miRNAs in PSD pathogenesis. The passways and pathomechanisms of relevant miRNAs is shown in <xref rid="t0001" ref-type="table">Table 1</xref>.<table-wrap id="t0001" orientation="landscape" position="float"><label>Table 1</label><caption><p>Passways and Pathomechanisms of miRNAs in Postoperative Sleep Disturbance</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Expression</th><th rowspan="1" colspan="1">Signaling Pathway(s)</th><th rowspan="1" colspan="1">Pathomechanism(s)</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">miR-26b</td><td rowspan="1" colspan="1">Up</td><td rowspan="1" colspan="1">Binds to IL-6 mRNA 3ʹUTR to hinder IL-6 transcription</td><td rowspan="1" colspan="1">Suppress microglia activation</td><td rowspan="1" colspan="1">Kang et al<xref rid="cit0086" ref-type="bibr">86</xref></td></tr><tr><td rowspan="1" colspan="1">Up</td><td rowspan="1" colspan="1">Inactivates BCL-2-related mitochondrial apoptosis pathway</td><td rowspan="1" colspan="1">Neuronal apoptosis</td><td rowspan="1" colspan="1">Gao et al<xref rid="cit0111" ref-type="bibr">111</xref></td></tr><tr><td rowspan="1" colspan="1">miR-188-5p</td><td rowspan="1" colspan="1">Up</td><td rowspan="1" colspan="1">Increases IL-6mRNA by targeting HNRNPA1</td><td rowspan="1" colspan="1">Induce cytokine transcription</td><td rowspan="1" colspan="1">Mosakhani et al<xref rid="cit0087" ref-type="bibr">87</xref></td></tr><tr><td rowspan="1" colspan="1">miR-155</td><td rowspan="1" colspan="1">Up</td><td rowspan="1" colspan="1">Induces TLR signalling pathway by suppressing c-Maf, SOCS1</td><td rowspan="1" colspan="1">Activate inflammation signaling pathway</td><td rowspan="1" colspan="1">Surbhi et al<xref rid="cit0092" ref-type="bibr">92</xref></td></tr><tr><td rowspan="1" colspan="1">miR-146a</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Down-regulates NF-κB by repressing IRAK1 and TRAF6</td><td rowspan="1" colspan="1">Inflammatory regulation</td><td rowspan="1" colspan="1">Nakano et al<xref rid="cit0093" ref-type="bibr">93</xref></td></tr><tr><td rowspan="1" colspan="1">miR-21</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Inhibits TLR4/TNF-α/IL-6R pathway</td><td rowspan="1" colspan="1">Suppress neuroinflammatory response</td><td rowspan="1" colspan="1">Chen et al<xref rid="cit0094" ref-type="bibr">94</xref></td></tr><tr><td rowspan="1" colspan="1">miR-23a</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Ehances TNF-α and IL-6 secretions</td><td rowspan="1" colspan="1">Induce inflammatory response</td><td rowspan="1" colspan="1">Chen et al<xref rid="cit0094" ref-type="bibr">94</xref></td></tr><tr><td rowspan="1" colspan="1">miR-224-5p</td><td rowspan="1" colspan="1">Up</td><td rowspan="1" colspan="1">Inhibits MALAT1/NLRP3/IL-1β</td><td rowspan="1" colspan="1">Reduce microglia activation</td><td rowspan="1" colspan="1">Du et al<xref rid="cit0095" ref-type="bibr">95</xref></td></tr><tr><td rowspan="2" colspan="1">miR-181c</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Reduces TLR4/NF-κB/p65 activation</td><td rowspan="1" colspan="1">Inflammatory regulation</td><td rowspan="1" colspan="1">Fang et al<xref rid="cit0096" ref-type="bibr">96</xref></td></tr><tr><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Promotes neurons remodeling by targeting TRIM2</td><td rowspan="1" colspan="1">Dendritic morphogenesis</td><td rowspan="1" colspan="1">Fang et al<xref rid="cit0096" ref-type="bibr">96</xref></td></tr><tr><td rowspan="1" colspan="1">miR-132</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Enhances synaptic growth by down-regulating p250GAP protein</td><td rowspan="1" colspan="1">Synaptic plasticity</td><td rowspan="1" colspan="1">Xu et al<xref rid="cit0099" ref-type="bibr">99</xref></td></tr><tr><td rowspan="1" colspan="1">miR-134</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Promotes dendrite growth by inhibiting Pumilio2</td><td rowspan="1" colspan="1">Drentritic growth</td><td rowspan="1" colspan="1">Fiore et al<xref rid="cit0100" ref-type="bibr">100</xref></td></tr><tr><td rowspan="1" colspan="1">miR-206</td><td rowspan="1" colspan="1">Up</td><td rowspan="1" colspan="1">Induces BDNF level</td><td rowspan="1" colspan="1">Neurotrophic factor</td><td rowspan="1" colspan="1">Zhao et al<xref rid="cit0103" ref-type="bibr">103</xref></td></tr><tr><td rowspan="1" colspan="1">miR-124</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Promotes the hypomethylation of BACE1 protein</td><td rowspan="1" colspan="1">Aβ production</td><td rowspan="1" colspan="1">Zhang et al<xref rid="cit0107" ref-type="bibr">107</xref></td></tr><tr><td rowspan="1" colspan="1">miR-195</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Regulats APP and BACE1 expression at the post-transcriptional level</td><td rowspan="1" colspan="1">Aβ aggregation</td><td rowspan="1" colspan="1">Sun et al<xref rid="cit0108" ref-type="bibr">108</xref></td></tr><tr><td rowspan="1" colspan="1">miR-207</td><td rowspan="1" colspan="1">Down</td><td rowspan="1" colspan="1">Modulates neurotrophins signaling</td><td rowspan="1" colspan="1">Synaptic plasticity</td><td rowspan="1" colspan="1">Gao et al<xref rid="cit0111" ref-type="bibr">111</xref></td></tr></tbody></table></table-wrap>
</p>
    </sec>
    <sec id="s0002">
      <title>Postoperative Sleep Disturbance</title>
      <sec id="s0002-s2001">
        <title>Sleep Structure and Function</title>
        <p>The normal sleep–wake cycle is naturally rhythmic.<xref rid="cit0012" ref-type="bibr">12</xref> According to the American Academy of Sleep Medicine, sleep–wake states can be divided into wakefulness, non-REM sleep, and REM sleep.<xref rid="cit0013" ref-type="bibr">13</xref> Compared with NREM, REM sleep is associated with stronger physiological activities, fluctuations in blood pressure and heart rate, irregular breathing, and increased brain metabolism.<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0015" ref-type="bibr">15</xref></p>
        <p>Long-term reductions in sleep time or complete sleep deprivation can cause cognitive deficits. Limiting sleep time to 4 h to 6 h per night can lead to neurobehavioral impairment upon waking, along with polysomnography results indicating prolonged REM latency and slight increase in SWS.<xref rid="cit0016" ref-type="bibr">16</xref> Additionally, sleep deprivation in the time window before and after learning can impair memory and learning ability, as REM sleep deprivation 3–6 h after learning significantly increases levels of brain-derived neurotrophic factor (BDNF) in the CA1 region of the hippocampus.<xref rid="cit0017" ref-type="bibr">17</xref> Based on the effectiveness of anti-tumour necrosis factor (TNF)-α therapy, Sochal et al<xref rid="cit0018" ref-type="bibr">18</xref> evaluated serum BDNF levels in Crohn’s disease patients and healthy controls to assess the relationship between BDNF concentration and the severity of insomnia, and identified a positive correlation between serum BDNF level and results of the Athens Insomnia Scale. These findings suggest that BDNF is involved in PSD-related mechanisms via modulating chronic inflammation.</p>
        <p>The interstitial fluid (ISF) of the brain transports soluble proteins, metabolic waste, and excess extracellular fluid along the paravenous drainage pathway, which relies on aquaporin 4 expressed in glial cells. Approximately 55% of soluble Aβ in the interstitium is cleared by the lymphoid pathway.<xref rid="cit0019" ref-type="bibr">19</xref> During sleep, the interstitial volume of the cerebral cortex increases by up to 60%, and the convection of ISF and cerebrospinal fluid (CSF) increases to enable effective clearance of Aβ. Both sleep and anaesthesia can improve clearance efficiency, indicating that the sleep state itself may be the main factor promoting the clearance of metabolic waste.<xref rid="cit0020" ref-type="bibr">20</xref></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Effects of PSD on Postoperative Outcomes</title>
        <p>Patients often show decreased daytime physical strength, functional limitations, and vulnerable emotions, which negatively affect post-surgery recovery. Severe PSD is manifested by changes in the sleep cycle. REM is significantly reduced on the night after surgery, followed by a rebound of REM sleep in the following 2 to 4 days and an increase in the proportion of REM sleep in total sleep time.<xref rid="cit0021" ref-type="bibr">21</xref> REM sleep rebound causes hemodynamic instability and changes in pulmonary ventilation, thereby increasing the incidence of postoperative fatigue, severe anxiety and depression, pain sensitivity, and cognitive dysfunction and also resulting in longer hospital stays.<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0023" ref-type="bibr">23</xref> Kessler et al<xref rid="cit0024" ref-type="bibr">24</xref> found that sleep disorders and low daytime physical activity reflect delayed recovery after discharge. Therefore, sleep intervention may be important for timely rehabilitation. Moreover, improving the sleep environment is recommended to alleviate sleep disturbances in postoperative patients.<xref rid="cit0025" ref-type="bibr">25</xref> Pharmacological methods, including administration of zolpidem, melatonin, and/or dexmedetomidine, have recently been employed to improve sleep post-discharge. Specifically, administration of zolpidem one night before and on the first night after surgery improves sleep quality and fatigue.<xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0026" ref-type="bibr">26</xref></p>
        <p>Sleep disturbances in AD patients are characterised by increased duration of awakenings, loss of SWS and REM sleep, and excessive daytime napping. AD patients spend a significant proportion of their day asleep, although this almost completely comprises stages 1 and 2 sleep, which barely compensates for night-time absences of SWS and REM sleep.<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0028" ref-type="bibr">28</xref> Thus, abnormal shifts in the sleep–wake rhythm of AD patients may be implicated in PSD, resulting in more prominent cognitive deficits.<xref rid="cit0029" ref-type="bibr">29</xref></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Exosomes</title>
      <sec id="s0003-s2001">
        <title>Exosome Formation and Production</title>
        <p>Exosome formation begins in the endocytic system of the cell, with formation of intraluminal vesicles when the cell compartment is recessed inward and buds outward. Although exosomes were originally considered the “garbage bin” of cells, studies have revealed that these vesicles are not specific products of reticulocytes but are rather released from most mammalian cells.<xref rid="cit0030" ref-type="bibr">30</xref> Later studies reported that exosomes released from mast cells contain ~1200 functional mRNAs, which could be transferred to other cells.<xref rid="cit0031" ref-type="bibr">31</xref> Exosomes participate in several key biological processes by delivering biologically active substances, such as DNA, RNA (mRNAs, miRNAs, and circular RNAs), and proteins. In the CNS, neuronal cells, microglia, and astrocytes secrete exosomes. As mediators of cell–cell communication, exosomes are related to amyloid degradation, brain clearance, and intercellular diffusion of tau, which can induce neuronal apoptosis and lead to neuron loss.<xref rid="cit0032" ref-type="bibr">32</xref></p>
        <p>Exosome production varies according to different cell states. Dutkowska et al<xref rid="cit0033" ref-type="bibr">33</xref> evaluated the expression of interleukin (IL)-1β, IL-6, and IL-17 in tumours versus surgical margins, and observed significantly higher expression of IL-6 in tumours relative to adjacent tissue, thereby indicating that inflammatory processes play a role in tumorigenesis. Additionally, they evaluated miR-9 and miR-122 as cytokine regulators in pre- and postoperative peripheral blood exosomes, revealing elevated levels of both miRs after tumour resection.</p>
        <p>A previous study investigating the expression of tissue inhibitor of metalloproteinases (TIMPs) in tumour and normal neighbouring tissues revealed decreased TIMP3 levels in non-cancerous tissue, whereas preoperative miR-17 expression in serum exosomes was significantly higher in cancer patients compared to healthy controls.<xref rid="cit0034" ref-type="bibr">34</xref> These findings suggest that exosome production can be influenced by removal of tumour tissue, which could enable the detection of early biomarkers related to tumorigenesis and metastasis.<xref rid="cit0035" ref-type="bibr">35–37</xref></p>
      </sec>
      <sec id="s0003-s2002">
        <title>Exosomes and Sleep Disorders</title>
        <p>Rhythmic activities, such as the sleep–wake cycle, are regulated by the circadian rhythm, which is an autonomous, endogenous oscillator in all living organisms and comprises transcriptionally active clock genes (<italic>CLOCK, BMAL1, PER1, PER2, PER3, CRY1</italic>, and <italic>CRY2</italic>) and their protein products. Khalyfa et al<xref rid="cit0038" ref-type="bibr">38</xref> found that <italic>Bmal1, Cry2</italic>, and <italic>Per1</italic> expression was significantly reduced in plasma exosomes obtained from mice with sleep-rhythm disorders, indicating that exosomes can act as a bridge between peripheral clock-controlled genes and central rhythms and transmit the effects of circadian-rhythm disorders to target organs, thereby disturbing end-organ homeostasis. In type 2 diabetes, visceral white adipose tissue secretes exosomes that transport functional proteins and RNAs, resulting in alteration of metabolic functions in nearby and distant tissues.<xref rid="cit0039" ref-type="bibr">39</xref> The associated molecular mechanism may involve α-subunit of hypoxia-inducible factor 1 (HIF-1α), which regulates oxygen metabolism. Hepatocyte-specific <italic>Hif1a</italic> knockout hindered this metabolic disorder by reducing GLP-1 degradation.<xref rid="cit0040" ref-type="bibr">40</xref> Moreover, several studies investigating the impact of blood oxygen saturation on HIF-1α mRNA levels showed decreases in these levels following continuous positive airway pressure (CPAP) treatment.<xref rid="cit0041" ref-type="bibr">41–43</xref> These findings support the hypothesis that hypoxia is an independent risk factor for insulin resistance.</p>
      </sec>
      <sec id="s0003-s2003">
        <title>The Role of Exosomes in the Pathogenesis of Sleep Disturbance</title>
        <sec id="s0003-s2003-s3001">
          <title>Amyloid Aggregation</title>
          <p>Rajendran et al<xref rid="cit0044" ref-type="bibr">44</xref> found that a fraction of Aβ in MVBs is loaded into exosomes and secreted into the extracellular environment. Aβ and its products are transferred to MVBs, followed by APP hydrolysis by β-secretase, which mainly occurs in early endosomes. The association between exosomes and Aβ suggests that inhibition of exosome secretion may reduce AD-like pathological processes; however, exosome function in the process of AD remains controversial.<xref rid="cit0045" ref-type="bibr">45</xref> Exosomes secreted in vivo in brains of APP-overexpressing mice contain higher levels of APP C-terminal fragments (CTFs) compared with normal brain tissue. These data support the hypothesis that an exosome-secretory pathway is beneficial to APP CTFs clearance.<xref rid="cit0046" ref-type="bibr">46</xref> An in vitro study by Kyongman et al<xref rid="cit0047" ref-type="bibr">47</xref> found that exosomes derived from N2a cells counteracted Aβ-mediated damage to synaptic plasticity and rescued long-term potentiation. Exosomes enhance the uptake of Aβ into microglia through their surface glycosphingolipids, and ultimately reduce the formation of amyloid plaques.</p>
          <p>The effect of sleep in amyloid pathogenesis has been assessed by wakefulness and sleep deprivation studies. Kang et al<xref rid="cit0048" ref-type="bibr">48</xref> monitored hippocampal Aβ levels in vivo using microdialysis in both wild-type mice and human APP transgenic (Tg2576) mice. They found that Aβ levels were significantly elevated during the waking period relative to the sleep period in control and Tg2576 mice, and that ISF Aβ levels positively correlated with wake-time duration. Xie et al<xref rid="cit0020" ref-type="bibr">20</xref> reported that sleep facilitates the clearance of Aβ from the ISF via the glymphatic system as observed on the two-photon imaging of the brain of adult mice, which revealed improved exchange between the glymphatic system and the systemic circulation in the brains of sleeping or anesthetised mice relative to awake mice. These findings suggest that attenuated clearance of Aβ under sleep-deprivation conditions may also contribute to increased ISF Aβ levels.</p>
          <p>Hypoxia can enhance Aβ production via increased expression of <italic>BACE1</italic>, which increases the activity of β-secretase and increases APP hydrolysis.<xref rid="cit0049" ref-type="bibr">49</xref> Bu et al<xref rid="cit0050" ref-type="bibr">50</xref> compared blood Aβ levels under oxygen saturation in 49 patients with OSA, and found that plasma Aβ levels positively correlated with hypoxic intensity. Additionally, to determine mechanism underlying hypoxia-induced increases in Aβ, Xie et al<xref rid="cit0051" ref-type="bibr">51</xref> investigated the effect of hypoxia on Aβ metabolism in a human neuroblastoma model stably expressing <italic>APP</italic>. They found that Aβ export via exosomes increased after exposure to hypoxia, and that expression of CD147, a transmembrane glycoprotein present on exosomes, was also elevated under hypoxic conditions. CD147 is a subunit of γ-secretase, and its degradation is inhibited by the tubulin HOOK1.<xref rid="cit0052" ref-type="bibr">52</xref> Cui et al<xref rid="cit0053" ref-type="bibr">53</xref> collected bone marrow-derived mesenchymal stem cells (MSCs) from <italic>App</italic> transgenic mice, found Aβ concentration decreased in the frontal cortex and hippocampus, and memory was improved which possibly due to an exosome-mediated increase in the expression of synapsin 1 and PSD95. Further clarification of the role of exosomes under hypoxic conditions will be beneficial for the prevention and treatment of abnormally increased Aβ levels caused by sleep disorders.</p>
        </sec>
        <sec id="s0003-s2003-s3002">
          <title>Tau Release and Transmission</title>
          <p>Sleep disorders cause hyperphosphorylation and aggregation of tau protein, resulting in formation of neurofibrillary tangles, neuritic plaques, and other structures. Compared with Aβ, pathological tau accumulation is more closely related to cognitive decline.<xref rid="cit0054" ref-type="bibr">54</xref> Tau spreads in the brain in a layered manner by first aggregating in the entorhinal cortex and then spreading to the hippocampus before eventually extending to the neocortex and surrounding areas. Sleep regulates the metabolic homeostasis in neurons. Holth et al<xref rid="cit0055" ref-type="bibr">55</xref> evaluated the effect of the sleep-wake cycle on tau levels in brain-tissue fluids in mice, and found that tau levels increased during the waking state and decreased during sleep; however not all protein levels increased in the CSF after sleep deprivation, and ISF tau level increased following prolonged wakefulness.</p>
          <p>The mechanism associated with tau release and diffusion in the brain has long been a focus of tau-pathology research. Recent studies have suggested that tau protein may spread among neurons via exosomes. Wang et al<xref rid="cit0056" ref-type="bibr">56</xref> found that cultured cerebral cortical neuron cells release tau through exosomes. However, compared with cytoplasmic tau, tau in exosomes was in a relatively low-phosphorylation state and accounted for &lt;2% of the total tau level. When intersynaptic connections are broken, exosomes cannot be taken up by neurons, which suggests that tau diffusion via exosomes depends on synaptic-structure integrity. Proteins (annexin 7 and Alix) extracted from the lysates of exosomes that secrete tau are involved in signal transduction and vesicle transport.<xref rid="cit0057" ref-type="bibr">57</xref> The recruitment of these proteins to exosomes may promote tau release; however, the specific molecular mechanism associated with tau release via exosomes remains unknown, and further research is needed to confirm this hypothesis.</p>
          <p>In vitro experiments indicate that tau mutations enhance their phosphorylation to promote tau release.<xref rid="cit0058" ref-type="bibr">58</xref> Recent evidence shows that sleep deprivation can activate different kinases and phosphatases in the brain, leading to tau hyperphosphorylation.<xref rid="cit0059" ref-type="bibr">59</xref> However, due to the dephosphorylation of tau by non-specific alkaline phosphatase in the brain, both phosphorylated and dephosphorylated tau proteins can exist outside the cells; therefore, it remains unclear whether phosphorylation promotes tau release.</p>
        </sec>
        <sec id="s0003-s2003-s3003">
          <title>Blood–Brain Barrier (BBB) Integrity</title>
          <p>The BBB is a multicellular vascular structure comprising pericytes, astrocytes, end feet, brain endothelial cells, and the tight junctions between endothelial cells, which control the metabolic exchange between brain and peripheral circulation to protect brain tissue from microorganisms or toxins.<xref rid="cit0060" ref-type="bibr">60</xref> Normal BBB function maintains brain homeostasis. Certain molecules in the brain, such as amyloid protein. TNF-α, and prostaglandins, move in and out of the CNS rhythmically.<xref rid="cit0061" ref-type="bibr">61</xref> Aβ periodically oscillates in the ISF of mouse brain tissues, and circadian-rhythm disorders can affect Aβ metabolism. Lack of the circadian-clock gene <italic>BMAL1</italic> leads to a decrease in daily Aβ oscillations and an increase in amyloid plaque formation.<xref rid="cit0062" ref-type="bibr">62</xref> The transport of Aβ through the BBB is one of the main steps in the Aβ metabolism. In rodents, ISF enters the brain parenchyma from the paravascular space of the arteries and flows out from the venous vascular space via the glymphatic system. Sleep can promote this pathway for clearing metabolic waste from the brain, and the interstitial space can increase by up to 60% during sleep, which may promote ISF and CSF convection.<xref rid="cit0020" ref-type="bibr">20</xref></p>
          <p>Decreased clearance of Aβ through the BBB is one of the mechanisms of pathological Aβ deposition.<xref rid="cit0063" ref-type="bibr">63</xref> Transporters at the BBB, such as receptor for advanced glycation end-products, low-density lipoprotein receptor-related protein 1, apolipoprotein, and P-glycoprotein (P-gp), mediate Aβ transfer from the brain to peripheral circulation.<xref rid="cit0064" ref-type="bibr">64</xref>,<xref rid="cit0065" ref-type="bibr">65</xref> Due to their structural and physiological characteristics, exosomes can enter the brain through the BBB. Pan et al<xref rid="cit0066" ref-type="bibr">66</xref> used recombinant brain microvascular endothelial cell exosomes to increase the expression of P-gp receptors, and found that exosomes enter cells via endocytosis and prevent the lysosome-mediated degradation of P-gp receptors. In mice, increased intracellular P-gp receptor levels reduce Aβ in the hippocampus and improve cognitive impairment caused by Aβ aggregation.</p>
          <p>After 6 days of sleep restriction, levels of the tight-junction proteins occludin, claudin-1, claudin-5, and zonula occludens (ZO)-2 were significantly reduced in the brain microvessels of mice but returned to the baseline levels in 24 h after resuming sleep.<xref rid="cit0067" ref-type="bibr">67</xref> Khalyfa et al<xref rid="cit0068" ref-type="bibr">68</xref> investigated the effects of plasma exosomes on different types of endothelial cells in 30 children with OSA. Compared with exosomes from children with normal cognitive function, plasma exosomes obtained from children with OSA altered the morphology of ZO-1 and increased BBB permeability, which indirectly affected the microenvironment and neural network in the brain. Following treatment with exosomes transfected with a specific mimic of miR-630, ZO-1 levels increased in endothelial cells, whereas transfection with selective inhibitors of miRNA-630 disrupted tight-junction permeability in endothelial cells.<xref rid="cit0069" ref-type="bibr">69</xref></p>
        </sec>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Exosomal miRNAs</title>
      <sec id="s0004-s2001">
        <title>miRNAs in Neurodegeneration</title>
        <p>miRNAs are noncoding RNAs of ~22 nucleotides that exist widely in eukaryotes. It is estimated that the human genome encodes &gt;1000 functional miRNAs that regulate the expression of 30% of protein-coding genes.<xref rid="cit0070" ref-type="bibr">70</xref> In the nucleus, primary transcription products are hydrolysed by ribonuclease III Drosha to generate miRNA precursors. These precursors are transferred to the cytoplasm and processed by Dicer to form mature miRNAs that bind to the 3ʹ untranslated region (UTR) of target mRNAs via RISC and Argonaute family proteins. This blocks translation initiation and results in translation inhibition or target degradation.<xref rid="cit0071" ref-type="bibr">71</xref> As key regulators of neuronal morphology and function, miRNAs are overexpressed in the brain during different developmental stages of the CNS. Loss of Dicer can cause dopaminergic neuronal death and neurodegeneration, while loss of Dicer in the cortex and hippocampus affects nerve cell development, suggesting that miRNAs play important regulatory roles in various cellular processes, including neuronal morphogenesis, neuronal apoptosis, and neurodegeneration.<xref rid="cit0072" ref-type="bibr">72</xref>,<xref rid="cit0073" ref-type="bibr">73</xref> With the discovery of exosome as a carrier of miRNAs, Xin et al demonstrated that in vitro MSCs stimulate the neurite outgrowth by transferring miR-133b to astrocytes and neurons via exosomes.<xref rid="cit0074" ref-type="bibr">74</xref> The regulatory role of miRNAs has also been noted in the inflammatory response. In animal models of persistent pulmonary hypertension, exosomes mediate a decrease in levels of monocyte chemoattractant proteins and mitogens through miRNAs, thereby inhibiting macrophage infiltration and proinflammatory-mediator release.<xref rid="cit0075" ref-type="bibr">75</xref></p>
        <p>Mutations in the apolipoprotein gene are risk factors for AD. The ε4 allele of this gene is a genetic risk factor for protein-related pathology characterised by misfolded protein deposition in neurodegenerative diseases.<xref rid="cit0076" ref-type="bibr">76</xref> Several studies have investigated the role of epigenetic mechanisms (mainly posttranscriptional modifications) in the pathogenesis of neurodegenerative diseases. Specifically, studies compared differential miRNA expression in the AD brain and revealed that miRNA-expression levels in the hippocampus, prefrontal cortex, CSF, and other tissues vary during the course of AD.<xref rid="cit0077" ref-type="bibr">77</xref> Neurodegeneration may result from changes in multiple cellular pathways. For example, miRNAs modulating central components of the amyloid cascade, such as APP and BACE1, have been identified.<xref rid="cit0078" ref-type="bibr">78</xref>,<xref rid="cit0079" ref-type="bibr">79</xref> Moreover, in the CNS, neurons, microglia, and astrocytes can be regulated by miRNAs via exosomes. Immunomodulatory miRNAs are involved in activating the inflammatory response of microglia, which is reportedly a key pathomechanism in AD.<xref rid="cit0080" ref-type="bibr">80</xref> Neurocognitive deficits are linked to loss of synaptic transmission and plasticity in murine models of AD, as well as AD patients. In this review, we have focused on how various miRNAs exert their modulatory function on AD-related biological pathways.</p>
      </sec>
      <sec id="s0004-s2002">
        <title>Putative Roles of miRNAs in Sleep Disturbance and Pathogenesis</title>
        <sec id="s0004-s2002-s3001">
          <title>The Neuroinflammatory Response</title>
          <p>After tissue injury or destruction, the inflammatory response can remove harmful substances and damaged tissues; however, excessive nervous system inflammation can cause neurotoxicity and cell death.<xref rid="cit0081" ref-type="bibr">81</xref> Activation of microglia is an important step in initiating the neuroinflammatory response. Cytokines IL-1, IL-6, and TNF-α can induce microglial differentiation into the M1 (proinflammatory) phenotype, whereas IL-4, IL-10, and other cytokines promote their differentiation into the M2 (anti-inflammatory) phenotype.<xref rid="cit0082" ref-type="bibr">82</xref> Additionally, Aβ deposition, tau phosphorylation, and neurofibrillary tangles can induce microglial differentiation into the M1 phenotype, leading to impaired axonal transport and APP aggregation.<xref rid="cit0083" ref-type="bibr">83</xref> Damaged neurons can also release Aβ to cause inflammation, initiating a cycle of continued Aβ release. CNS inflammation can affect neurotrophic factor levels, thereby damaging synaptic plasticity and leading to decreased nerve regeneration ability.<xref rid="cit0084" ref-type="bibr">84</xref> Wadhwa et al<xref rid="cit0085" ref-type="bibr">85</xref> showed that after 48 h sleep deprivation, levels of IL-1, IL-6, and TNF-α increased significantly in the hippocampus of mice and resulted in impaired spatial memory; however, following minocycline treatment, the BDNF level increased significantly in the brain.</p>
          <p>A previous report indicated that miR-26b suppressed microglial activation and decreased the levels of IL-6 in the CA1 region of the hippocampus. This study also showed that miR-26b can bind the 3′ UTR of IL-6 to inhibit its transcription, thereby effectively reducing neuronal apoptosis.<xref rid="cit0086" ref-type="bibr">86</xref> Excessive daytime sleep leads to increased levels of miR-188-5p, which targets heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), a transcriptional regulator of IL-6. A previous study showed that HNRNPA1 overexpression increases IL-6 mRNA expression.<xref rid="cit0087" ref-type="bibr">87</xref> miR-188-5p acts as a tumour suppressor and is related to ventricular remodelling and synaptic plasticity.<xref rid="cit0088" ref-type="bibr">88</xref>,<xref rid="cit0089" ref-type="bibr">89</xref> Ni et al<xref rid="cit0090" ref-type="bibr">90</xref> reported that <italic>BMAL1</italic> expression in microglia is significantly reduced in <italic>App</italic> transgenic mice with a disturbed sleep cycle, whereas mRNA expression of <italic>Tnfa, Il1b</italic>, and <italic>Il6</italic> was increased. Experimental results indicate that decreased BMAL1 expression reduces the negative regulatory effect of IκBα on NF-κB, thus, upregulating NF-κB and leading to increased <italic>Tnfa, Il1b</italic>, and <italic>Il6</italic> transcription.</p>
          <p>Toll-like receptors (TLRs) are surface receptors expressed on various cells, including microglia. TLR activation induces. Although TLRs are not exclusively expressed in microglia, the activation of downstream inflammatory signalling pathways by TLRs is an important step in AD pathogenesis.<xref rid="cit0091" ref-type="bibr">91</xref> miRNAs can participate in TLR-mediated inflammation signalling pathways at different levels. miR-155 can promote TLR activation by inhibiting negative regulators of TLR, such as c-Maf and suppressor of cytokine signalling 1. In animal models, miR-155 knockout reduces the sleep-promoting effect of endotoxin, increases wakefulness time, and reduces NREM, suggesting its role as a mediator of the regulatory effect of sleep on the immune response.<xref rid="cit0092" ref-type="bibr">92</xref> By contrast, miR-146a acts as an anti-inflammatory regulator in the brain. Upon injection of bone marrow-derived MSC exosomes into the brains of AD mice, microglia differentiated into the M2 phenotype, and astrocytes began to take up exosomes, followed by miR-146-mediated reductions in levels of NF-κB.<xref rid="cit0093" ref-type="bibr">93</xref> In addition to miR-155 and miR-146a, miR-21, miR-23, miR-224-5p, and miR-181c regulate proteins involved in the TLR signalling pathway.<xref rid="cit0094" ref-type="bibr">94–96</xref>
<italic>TRIM2</italic>, a target of miR-181c, reduces the ubiquitination of nerve-fibre filaments (neurofilament light), and promotes neuronal remodelling in the hippocampus exposed to hypoxia.<xref rid="cit0096" ref-type="bibr">96</xref> Although activation of the inflammatory pathway is clearly an important factor in the development of cognitive impairment, additional research is needed to identify a direct link.</p>
        </sec>
        <sec id="s0004-s2002-s3002">
          <title>Neuroregeneration</title>
          <p>The upregulated transcription of miRNAs in specific brain regions is driven by neuronal activity. For instance, miR-132 expression is transcriptionally stimulated by neural activity and regulated by the cAMP response element-binding protein (CREB) signalling pathway. Aβ downregulates BDNF levels in AD by inhibiting the transcription of CREB, a downstream target of BDNF, thereby resulting in early decreases in miR-132.<xref rid="cit0097" ref-type="bibr">97</xref> Furthermore, deletion of miR-132 in <italic>App</italic> transgenic mice enhances amyloid plaque accumulation and tau protein phosphorylation.<xref rid="cit0098" ref-type="bibr">98</xref> However, in AD-induced synaptic dysfunction, the effects of miRNA-mediated downstream gene dysregulation remains unknown.</p>
          <p>Recent studies have revealed that a lack of miR-132 may lead to a decreased number of dendrites, which is closely related to the loss of synaptic function and cognitive impairment. Following transfection of miR-132 into AD mice, expression of the synaptic proteins PSD95, synapsin-1, and p-synapsin increased significantly in the temporal cortex and memory deficit was partially restored.<xref rid="cit0099" ref-type="bibr">99</xref> Changes in synaptic plasticity and imbalances in the regulatory mechanism are related to the destruction of neural circuits, especially of the complex neuronal network formed by dendritic spines. There exists a complex miRNA-transcription-feedback system in the brain. For example, miR-134 expression is strictly regulated by synaptic activity via the transcription factor MEF2; miR-134 promotes dendritic growth by inhibiting Pumilio2.<xref rid="cit0100" ref-type="bibr">100</xref> Additionally, (sirtuin 1) SIRT1 is an NAD+-dependent protein acylase that can reduce miR-134 expression via an inhibitor complex containing the transcription factor YY1. A decrease in SIRT1 activity leads to increase in miR-134 levels, resulting in downregulation of CREB and BDNF levels, and impairment of synaptic plasticity.<xref rid="cit0101" ref-type="bibr">101</xref> Patients with AD exhibit increased miR-134 expression in CSF, and AD exosomes contain higher levels of miR-134.<xref rid="cit0102" ref-type="bibr">102</xref> Furthermore, miR-134 can modulate exosomal transport, which is involved in AD pathogenicity, and miR-206-knockdown exosomes increase BDNF expression and inhibit neuronal apoptosis following acute brain injury.<xref rid="cit0103" ref-type="bibr">103</xref> These findings suggest the feasibility of exosomal miRNAs as therapeutic markers.</p>
        </sec>
        <sec id="s0004-s2002-s3003">
          <title>Cerebral Hemodynamic Changes</title>
          <p>Chronic cerebral hypoperfusion and decreased glucose metabolism before cognitive decline are high-risk factors for AD.<xref rid="cit0104" ref-type="bibr">104</xref> Due to decreased lung ventilation, brain metabolism and cerebral blood flow are reduced during NREM sleep.<xref rid="cit0015" ref-type="bibr">15</xref> Brayet et al monitored cerebral blood flow during REM sleep and found that hypoperfusion of the anterior cingulate gyrus under REM is related to functional defects, which may lead to the onset of AD.<xref rid="cit0105" ref-type="bibr">105</xref> miRNAs regulate BACE1 and APP expression at the posttranscriptional level; numerous transcription factor-binding sites have been identified in the promoter regions of <italic>BACE1</italic> and <italic>APP</italic> to complement these miRNAs, suggesting an important role of miRNAs in the pathogenesis of cerebral blood-flow deficiency.<xref rid="cit0106" ref-type="bibr">106</xref></p>
          <p>In vivo experiments have shown that hypoxia or Aβ downregulates miR-124 expression in the hippocampus. The underlying mechanism might involve activation of the exchange protein activated by cAMP (EPAC)–Rap1 pathway. Downregulation of miR-124 promotes hypomethylation of BACE1, increases BACE1 levels in the hippocampus, and leads to increased Aβ production.<xref rid="cit0107" ref-type="bibr">107</xref> Unlike miR-124, miR-195 can reduce Aβ production under chronic cerebral hypoperfusion and thereby protect neurons; this effect is possibly related to negative regulation of NF-κB.<xref rid="cit0105" ref-type="bibr">105</xref>,<xref rid="cit0108" ref-type="bibr">108</xref> As an imbalanced miRNA expression is related to neuronal damage caused by cerebral insufficiency, promoting normal miRNA function may thus, have a protective effect on cerebral blood flow.</p>
        </sec>
        <sec id="s0004-s2002-s3004">
          <title>Apoptosis</title>
          <p>Hypoxia, insufficient energy, inflammatory responses, and Aβ and tau proteins increase the accumulation of ROS in nerve cells and cause mitochondrial DNA mutations. miRNAs and their downstream molecules can regulate apoptosis pathways, as downregulation of miR-26 inactivates the BCL-2-related mitochondrial apoptosis pathway and activates Bax to induce apoptosis of liver cancer cells.<xref rid="cit0109" ref-type="bibr">109</xref> Circadian-rhythm disorders affect DNA repair, cell cycle, and cell apoptosis and are associated with neurodegenerative diseases and cancer.<xref rid="cit0110" ref-type="bibr">110</xref> Gao et al<xref rid="cit0111" ref-type="bibr">111</xref> found that intermittent hypoxia affects the expression of pro-apoptotic and anti-apoptotic proteins in the hippocampus of a mouse model of OSA. Additionally, they found that miR-26b expression in the hippocampus increased three-fold, whereas miR-207 expression remained low in response to intermittent hypoxia. Moreover, miR-207 may play a protective role by participating in autophagy, as a murine model of PD showed that miR-207 inhibited apoptosis of mesencephalon-derived dopaminergic neuronal cells, suggesting that miR-207 may be a potential therapeutic target of PD.<xref rid="cit0112" ref-type="bibr">112</xref> Recently, some studies investigated the feasibility of modulated miR-125b/p38 mitogen-activated protein kinase (MAPK) signalling to induce varying levels of neurons apoptosis. One study showed that upregulating p38 MAPK via loss of miR125b expression could regulate the expression of apoptosis-specific proteins in SH-SY5Y cells.<xref rid="cit0113" ref-type="bibr">113</xref> Furthermore, p38 MAPK was reported to play a role in cascade reactions involved in inflammation, oxidative stress, and Aβ-mediated cell apoptosis.<xref rid="cit0114" ref-type="bibr">114</xref></p>
        </sec>
      </sec>
    </sec>
    <sec id="s0005">
      <title>Exosomes and Exosomal miRNAs as Potential Treatment options for PSD</title>
      <p>A large body of evidence indicates that sleep disorders may be involved in the pathogenesis of neurodegenerative diseases and increase the risk of dementia.<xref rid="cit0115" ref-type="bibr">115</xref> Exosomal miRNAs participate in sleep-disorder pathogenicity via two mechanisms: 1) direct regulation of signal pathway components or 2) regulation of proteins involved in signal pathways or key enzymes.<xref rid="cit0116" ref-type="bibr">116</xref>,<xref rid="cit0117" ref-type="bibr">117</xref> Exosomes can carry altered genetic material derived from diseased cell and appear in early or advanced disease stages. In <italic>App</italic> transgenic mice, rabies virus-modified MSC-derived exosomes significantly reduced soluble Aβ40 and Aβ42 levels in the brain. Furthermore, following exosome treatment, expression of TNF-α and IL-1β and levels of glial fibrillary acidic protein decreased, whereas glial cell function was significantly improved.<xref rid="cit0118" ref-type="bibr">118</xref> In mice, MSC-derived exosomes significantly increased miR-21 levels after hypoxic preconditioning, resulting in downregulation of signal transducer and activator of transcription 3 phosphorylation and inhibition of NF-kB activation, which reduced the neuroinflammatory response in the brain.<xref rid="cit0094" ref-type="bibr">94</xref> Additionally, other studies reported that miR-21 levels are related to attenuated inflammatory responses, and that reduced miR-206 expression via exosome delivery upregulates BDNF/tropomyosin receptor kinase B/CREB signalling, which exerts a neuroprotective effect on subarachnoid haemorrhage.<xref rid="cit0103" ref-type="bibr">103</xref> Exosomes are naturally produced by human cells. Compared with other carriers of gene therapy, exosomes are advantageous in terms of achieving therapeutic effect, lower immune rejection, and better targeting.<xref rid="cit0119" ref-type="bibr">119</xref> The delivery of therapeutic RNAs to target cells via exosomes for correcting protein dysfunction is a potential therapeutic strategy for brain diseases characterised by genetic abnormalities.<xref rid="cit0120" ref-type="bibr">120</xref> Notably, exosomal miRNAs can act on different target genes, and expression of one gene can be regulated by multiple miRNAs. This suggests that intervention based on targeting the activity and/or treatment of a single gene would have limited efficacy. Moreover, sequential gene damage caused by sleep disorders requires a multi-pronged therapeutic approach for improving memory and learning dysfunctions.</p>
    </sec>
    <sec id="s0006">
      <title>Conclusion</title>
      <p>Exosomes represent potential tools to therapeutically target sleep-disorder pathogenesis. Studies show that exosomes can promote protein misfolding and hinder their successful translation. Furthermore, miRNAs transferred by exosomes modulate the neuroinflammatory cascade, Aβ generation, and neuronal apoptosis. The role of exosomes in pathological mechanisms related to neuronal damage offers insights into their potential roles as biomarkers of and therapeutic targets for sleep-induced neuronal dysfunction. Elucidating the underlying mechanisms will promote the establishment of sleep-disorder models, prediction of dementia risk, and devise gene-therapy strategies. Future work should focus on detailed investigation of changes in exosome status and exosomal miRNAs under different types of sleep disturbance for disease prevention and early-stage diagnosis.</p>
    </sec>
  </body>
  <back>
    <sec id="s0007">
      <title>Ethical Approval</title>
      <p>Not applicable</p>
    </sec>
    <sec id="s0008">
      <title>Informed Consent</title>
      <p>Not applicable</p>
    </sec>
    <sec id="s0009" sec-type="COI-statement">
      <title>Disclosure</title>
      <p>There are no competing interests to declare.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gögenur</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Wildschiøtz</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Rosenberg</surname>
<given-names>J</given-names></string-name>. <article-title>Circadian distribution of sleep phases after major abdominal surgery</article-title>. <source><italic toggle="yes">Br J Anaesth</italic></source>. <year>2008</year>;<volume>100</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bja/aem340</pub-id><pub-id pub-id-type="pmid">18037670</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rampes</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Katie</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Divecha</surname>
<given-names>YA</given-names></string-name>, et al. <article-title>Postoperative sleep disorders and their potential impacts on surgical outcomes</article-title>. <source><italic toggle="yes">J Biomed Res</italic></source>. <year>2019</year>;<volume>34</volume>(<issue>4</issue>):<fpage>271</fpage>–<lpage>280</lpage>. doi:<pub-id pub-id-type="doi">10.7555/JBR.33.20190054</pub-id><pub-id pub-id-type="pmid">32519977</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sipilä</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Kalso</surname>
<given-names>EA</given-names></string-name>. <article-title>Sleep well and recover faster with less pain-a narrative review on sleep in the perioperative period</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2021</year>;<volume>10</volume>(<issue>9</issue>):<fpage>2000</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm10092000</pub-id><pub-id pub-id-type="pmid">34066965</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Yegneswaran</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Shapiro</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>W</given-names></string-name>. <article-title>Postoperative changes in sleep-disordered breathing and sleep architecture in patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Anesthesiology</italic></source>. <year>2014</year>;<volume>120</volume>(<issue>2</issue>):<fpage>287</fpage>–<lpage>298</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000000040</pub-id><pub-id pub-id-type="pmid">24158049</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shokri-Kojori</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>G-J</given-names></string-name>, <string-name><surname>Wiers</surname>
<given-names>CE</given-names></string-name>, et al. <article-title>β-Amyloid accumulation in the human brain after one night of sleep deprivation</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci U S A</italic></source>. <year>2018</year>;<volume>115</volume>(<issue>17</issue>):<fpage>4483</fpage>–<lpage>4488</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1721694115</pub-id><pub-id pub-id-type="pmid">29632177</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bah</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Goodman</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Iliff</surname>
<given-names>JJ</given-names></string-name>. <article-title>Sleep as a therapeutic target in the aging brain</article-title>. <source><italic toggle="yes">Neurotherapeutics.</italic></source>
<year>2019</year>;<volume>16</volume>(<issue>3</issue>):<fpage>554</fpage>–<lpage>568</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13311-019-00769-6</pub-id><pub-id pub-id-type="pmid">31376067</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Su</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>D-X</given-names></string-name>. <article-title>Improve postoperative sleep: what can we do?</article-title>
<source><italic toggle="yes">Curr Opin Anaesthesiol</italic></source>. <year>2018</year>;<volume>31</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ACO.0000000000000538</pub-id><pub-id pub-id-type="pmid">29120927</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cai</surname>
<given-names>Z-Y</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Quazi</surname>
<given-names>SH</given-names></string-name>. <article-title>Exosomes: a novel therapeutic target for Alzheimer’s disease?</article-title>
<source><italic toggle="yes">Neural Regen Res</italic></source>. <year>2018</year>;<volume>13</volume>(<issue>5</issue>):<fpage>930</fpage>–<lpage>935</lpage>. doi:<pub-id pub-id-type="doi">10.4103/1673-5374.232490</pub-id><pub-id pub-id-type="pmid">29863025</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cheng</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sharples</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Scicluna</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>AF</given-names></string-name>. <article-title>Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2014</year>;<volume>3</volume>. doi:<pub-id pub-id-type="doi">10.3402/jev.v3.23743</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Goetzl</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Kapogiannis</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>JB</given-names></string-name>, et al. <article-title>Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease</article-title>. <source><italic toggle="yes">FASEB J</italic></source>. <year>2016</year>;<volume>30</volume>(<issue>12</issue>):<fpage>4141</fpage>–<lpage>4148</lpage>. doi:<pub-id pub-id-type="doi">10.1096/fj.201600816R</pub-id><pub-id pub-id-type="pmid">27601437</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Goetzl</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Boxer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>JB</given-names></string-name>, et al. <article-title>Altered lysosomal proteins in neural derived plasma exosomes in preclinical Alzheimer disease</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2015</year>;<volume>85</volume>(<issue>1</issue>):<fpage>40</fpage>–<lpage>47</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000001702</pub-id><pub-id pub-id-type="pmid">26062630</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Rogut</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>, et al. <article-title>The impact of glucocorticoids and statins on sleep quality</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2021</year>;<volume>55</volume>:<fpage>101380</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2020.101380</pub-id><pub-id pub-id-type="pmid">33010620</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Maschauer</surname>
<given-names>EL</given-names></string-name>, et al. <article-title>Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2020</year>;<volume>71</volume>:<fpage>48</fpage>–<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2020.03.009</pub-id><pub-id pub-id-type="pmid">32492554</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McNamara</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>P</given-names></string-name>, <string-name><surname>McLaren</surname>
<given-names>D</given-names></string-name>, et al. <article-title>REM and NREM sleep mentation</article-title>. <source><italic toggle="yes">Int Rev Neurobiol</italic></source>. <year>2010</year>;<volume>92</volume>:<fpage>69</fpage>–<lpage>86</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0074-7742(10)92004-7</pub-id><pub-id pub-id-type="pmid">20870063</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Brooks</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gamaldo</surname>
<given-names>C</given-names></string-name>, et al. <article-title>AASM Scoring Manual Updates for 2017 (Version 2.4)</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2017</year>;<volume>13</volume>(<issue>5</issue>):<fpage>665</fpage>–<lpage>666</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.6576</pub-id><pub-id pub-id-type="pmid">28416048</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Van Dongen</surname>
<given-names>HPA</given-names></string-name>, <string-name><surname>Maislin</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mullington</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Dinges</surname>
<given-names>DF</given-names></string-name>. <article-title>The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2003</year>;<volume>26</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>126</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/26.2.117</pub-id><pub-id pub-id-type="pmid">12683469</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Karabulut</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bayramov</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Bayramov</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Effects of post-learning REM sleep deprivation on hippocampal plasticity-related genes and microRNA in mice</article-title>. <source><italic toggle="yes">Behav Brain Res.</italic></source>
<year>2019</year>;<volume>361</volume>:<fpage>7</fpage>–<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2018.12.045</pub-id><pub-id pub-id-type="pmid">30594545</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Małecka-Panas</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Brain-derived neurotrophic factor is elevated in the blood serum of Crohn’s disease patients, but is not influenced by anti-TNF-α treatment-a pilot study</article-title>. <source><italic toggle="yes">Neurogastroenterol Motil</italic></source>. <year>2020</year>;<volume>e13978</volume>. doi:<pub-id pub-id-type="doi">10.1111/nmo.13978</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Iliff</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β</article-title>. <source><italic toggle="yes">Sci Transl Med</italic></source>. <year>2012</year>;<volume>4</volume>(<issue>147</issue>):<fpage>147ra111</fpage>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3003748</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xie</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Qiwu</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Sleep drives metabolite clearance from the adult brain</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2013</year>;<volume>342</volume>(<issue>6156</issue>):<fpage>373</fpage>–<lpage>377</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1241224</pub-id><pub-id pub-id-type="pmid">24136970</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Elsaid</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Factors associated with postoperative exacerbation of sleep-disordered breathing</article-title>. <source><italic toggle="yes">Anesthesiology</italic></source>. <year>2014</year>;<volume>120</volume>(<issue>2</issue>):<fpage>299</fpage>–<lpage>311</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000000041</pub-id><pub-id pub-id-type="pmid">24158050</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dette</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cassel</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Urban</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Occurrence of rapid eye movement sleep deprivation after surgery under regional anesthesia</article-title>. <source><italic toggle="yes">Anesth Analg</italic></source>. <year>2013</year>;<volume>116</volume>(<issue>4</issue>):<fpage>939</fpage>–<lpage>943</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0b013e3182860e58</pub-id><pub-id pub-id-type="pmid">23460574</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kjølhede</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Langström</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Nilsson</surname>
<given-names>P</given-names></string-name>, et al. <article-title>The impact of quality of sleep on recovery from fast-track abdominal hysterectomy</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2012</year>;<volume>8</volume>(<issue>4</issue>):<fpage>395</fpage>–<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.2032</pub-id><pub-id pub-id-type="pmid">22893770</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kessler</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Knutson</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Mokhlesi</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Sleep and activity patterns in older patients discharged from the hospital</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>11</issue>):<fpage>zsz153</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsz153</pub-id><pub-id pub-id-type="pmid">31310317</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Alessi</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Webber</surname>
<given-names>AP</given-names></string-name>, et al. <article-title>Randomized, controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>2005</year>;<volume>53</volume>(<issue>5</issue>):<fpage>803</fpage>–<lpage>810</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.53251.x</pub-id><pub-id pub-id-type="pmid">15877555</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Krenk</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jennum</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kehlet</surname>
<given-names>H</given-names></string-name>. <article-title>Postoperative sleep disturbances after zolpidem treatment in fast-track hip and knee replacement</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2014</year>;<volume>10</volume>(<issue>3</issue>):<fpage>321</fpage>–<lpage>326</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.3540</pub-id><pub-id pub-id-type="pmid">24634631</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Musiek</surname>
<given-names>ES</given-names></string-name>. <article-title>Circadian clock disruption in neurodegenerative diseases: cause and effect?</article-title>
<source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2015</year>;<volume>6</volume>:<fpage>29</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2015.00029</pub-id><pub-id pub-id-type="pmid">25774133</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vecchierin</surname>
<given-names>M-F</given-names></string-name>. <article-title>Sleep disturbances in Alzheimer’s disease and other dementias</article-title>. <source><italic toggle="yes">Psychol Neuropsychiatr Vieil</italic></source>. <year>2010</year>;<volume>8</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1684/pnv.2010.0203</pub-id><pub-id pub-id-type="pmid">20215095</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Henry</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Katsoulis</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Masi</surname>
<given-names>S</given-names></string-name>, et al. <article-title>The relationship between sleep duration, cognition and dementia: a Mendelian randomization study</article-title>. <source><italic toggle="yes">Int J Epidemiol</italic></source>. <year>2019</year>;<volume>48</volume>(<issue>3</issue>):<fpage>849</fpage>–<lpage>860</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ije/dyz071</pub-id><pub-id pub-id-type="pmid">31062029</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Raposo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Stoorvogel</surname>
<given-names>W</given-names></string-name>. <article-title>Extracellular vesicles: exosomes, microvesicles, and friends</article-title>. <source><italic toggle="yes">J Cell Biol</italic></source>. <year>2013</year>;<volume>200</volume>(<issue>4</issue>):<fpage>37383</fpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.201211138</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Valadi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ekström</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bossios</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells</article-title>. <source><italic toggle="yes">Nat Cell Biol</italic></source>. <year>2007</year>;<volume>9</volume>(<issue>6</issue>):<fpage>654</fpage>–<lpage>659</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb1596</pub-id><pub-id pub-id-type="pmid">17486113</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kalluri</surname>
<given-names>R</given-names></string-name>, <string-name><surname>LeBleu</surname>
<given-names>VS</given-names></string-name>. <article-title>The biology, function, and biomedical applications of exosomes</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2020</year>;<volume>367</volume>(<issue>6478</issue>):<fpage>eaau6977</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aau6977</pub-id><pub-id pub-id-type="pmid">32029601</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dutkowska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kaszkowiak</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Expression of inflammatory interleukins and selected miRNAs in non-small cell lung cancer</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>5092</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-021-84408-1</pub-id><pub-id pub-id-type="pmid">33658555</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Czarneck</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Barańska</surname>
<given-names>M</given-names></string-name>, et al. <article-title>A strong decrease in TIMP3 expression mediated by the presence of miR-17 and 20a enables extracellular matrix remodeling in the NSCLC lesion surroundings</article-title>. <source><italic toggle="yes">Front Oncol</italic></source>. <year>2019</year>;<volume>9</volume>:<fpage>1372</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fonc.2019.01372</pub-id><pub-id pub-id-type="pmid">31921636</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Shan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, et al. <article-title>A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients</article-title>. <source><italic toggle="yes">Oncotarget</italic></source>. <year>2017</year>;<volume>8</volume>(<issue>49</issue>):<fpage>86897</fpage>–<lpage>86907</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.19666</pub-id><pub-id pub-id-type="pmid">29156844</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Molina-Pinelo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dolores Pastor</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Suarez</surname>
<given-names>R</given-names></string-name>, et al. <article-title>MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2014</year>;<volume>43</volume>(<issue>6</issue>):<fpage>1740</fpage>–<lpage>1749</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00091513</pub-id><pub-id pub-id-type="pmid">24743967</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aushev</surname>
<given-names>VN</given-names></string-name>, <string-name><surname>Zborovskaya</surname>
<given-names>IB</given-names></string-name>, <string-name><surname>Laktionov</surname>
<given-names>KK</given-names></string-name>, et al. <article-title>Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e78649</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0078649</pub-id><pub-id pub-id-type="pmid">24130905</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Khalyfa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Poroyko</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Qiao</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Exosomes and metabolic function in mice exposed to alternating dark-light cycles mimicking night shift work schedules</article-title>. <source><italic toggle="yes">Front Physiol</italic></source>. <year>2017</year>;<volume>8</volume>:<fpage>882</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2017.00882</pub-id><pub-id pub-id-type="pmid">29163218</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>M-J</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>D-H</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>J-H</given-names></string-name>. <article-title>Exosomes as the source of biomarkers of metabolic diseases</article-title>. <source><italic toggle="yes">Ann Pediatr Endocrinol Metab</italic></source>. <year>2016</year>;<volume>21</volume>(<issue>3</issue>):<fpage>119</fpage>–<lpage>125</lpage>. doi:<pub-id pub-id-type="doi">10.6065/apem.2016.21.3.119</pub-id><pub-id pub-id-type="pmid">27777903</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Karuga</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>HIF-1α as a mediator of insulin resistance, T2DM, and its complications: potential links with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Front Physiol.</italic></source>
<year>2020</year>;<volume>11</volume>:<fpage>1035</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2020.01035</pub-id><pub-id pub-id-type="pmid">33013447</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Szemraj</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2020</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1761</fpage>–<lpage>1768</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8682</pub-id><pub-id pub-id-type="pmid">32663129</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Panek</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Serum hypoxia-inducible factor-1α protein level as a diagnostic marker of obstructive sleep apnea</article-title>. <source><italic toggle="yes">Pol Arch Intern Med</italic></source>. <year>2020</year>;<volume>130</volume>(<issue>2</issue>):<fpage>158</fpage>–<lpage>160</lpage>. doi:<pub-id pub-id-type="doi">10.20452/pamw.15104</pub-id><pub-id pub-id-type="pmid">31834288</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Relationship between HIF-1 and circadian clock proteins in obstructive sleep apnea patients-preliminary study</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>5</issue>):<fpage>1599</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm9051599</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rajendran</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Honsho</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zahn</surname>
<given-names>TR</given-names></string-name>, et al. <article-title>Alzheimer’s disease beta-amyloid peptides are released in association with exosomes</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci U S A</italic></source>. <year>2006</year>;<volume>103</volume>(<issue>30</issue>):<fpage>11172</fpage>–<lpage>11177</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0603838103</pub-id><pub-id pub-id-type="pmid">16837572</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dinkins</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Dasgupta</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease</article-title>. <source><italic toggle="yes">Neurobiol Aging</italic></source>. <year>2014</year>;<volume>35</volume>(<issue>8</issue>):<fpage>1792</fpage>–<lpage>1800</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.02.012</pub-id><pub-id pub-id-type="pmid">24650793</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Perez-Gonzalez</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gauthier</surname>
<given-names>SA</given-names></string-name>, et al. <article-title>The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2012</year>;<volume>287</volume>(<issue>51</issue>):<fpage>43108</fpage>–<lpage>43115</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M112.404467</pub-id><pub-id pub-id-type="pmid">23129776</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kyongman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Klyubin</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo</article-title>. <source><italic toggle="yes">Mol Brain</italic></source>. <year>2013</year>;<volume>6</volume>:<fpage>47</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1756-6606-6-47</pub-id><pub-id pub-id-type="pmid">24284042</pub-id></mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>J-E</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Bateman</surname>
<given-names>RJ</given-names></string-name>, et al. <article-title>Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2009</year>;<volume>326</volume>(<issue>5955</issue>):<fpage>1005</fpage>–<lpage>1007</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1180962</pub-id><pub-id pub-id-type="pmid">19779148</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Salminen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kauppinen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kaarniranta</surname>
<given-names>K</given-names></string-name>. <article-title>Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer’s disease</article-title>. <source><italic toggle="yes">J Neurochem</italic></source>. <year>2017</year>;<volume>140</volume>(<issue>4</issue>):<fpage>536</fpage>–<lpage>549</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnc.13932</pub-id><pub-id pub-id-type="pmid">27987381</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bu</surname>
<given-names>X-L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y-H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Q-H</given-names></string-name>, et al. <article-title>Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2015</year>;<volume>5</volume>:<fpage>13917</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep13917</pub-id><pub-id pub-id-type="pmid">26351108</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xie</surname>
<given-names>J-C</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>X-Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>X-H</given-names></string-name>, et al. <article-title>Hypoxia increases amyloid-β level in exosomes by enhancing the interaction between CD147 and Hook1</article-title>. <source><italic toggle="yes">Am J Transl Res</italic></source>. <year>2018</year>;<volume>10</volume>(<issue>1</issue>):<fpage>150</fpage>–<lpage>163</lpage>.<pub-id pub-id-type="pmid">29423001</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Walian</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Jap</surname>
<given-names>BK</given-names></string-name>. <article-title>The discovery and role of CD147 as a subunit of gamma-secretase complex</article-title>. <source><italic toggle="yes">Drug News Perspect</italic></source>. <year>2006</year>;<volume>19</volume>(<issue>3</issue>):<fpage>133</fpage>–<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1358/dnp.2006.19.3.985932</pub-id><pub-id pub-id-type="pmid">16804564</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cui</surname>
<given-names>G-H</given-names></string-name>, <string-name><surname>Jing</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Mou</surname>
<given-names>F-F</given-names></string-name>, et al. <article-title>Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice</article-title>. <source><italic toggle="yes">FASEB J</italic></source>. <year>2018</year>;<volume>32</volume>(<issue>2</issue>):<fpage>654</fpage>–<lpage>668</lpage>. doi:<pub-id pub-id-type="doi">10.1096/fj.201700600R</pub-id><pub-id pub-id-type="pmid">28970251</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brier</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Gordon</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Friedrichsen</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease</article-title>. <source><italic toggle="yes">Sci Transl Med</italic></source>. <year>2016</year>;<volume>8</volume>(<issue>338</issue>):<fpage>338ra66</fpage>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.aaf2362</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Holth</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Fritschi</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, et al. <article-title>The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2019</year>;<volume>363</volume>(<issue>6429</issue>):<fpage>880</fpage>–<lpage>884</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aav2546</pub-id><pub-id pub-id-type="pmid">30679382</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Balaji</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Kaniyappan</surname>
<given-names>S</given-names></string-name>, et al. <article-title>The release and trans-synaptic transmission of Tau via exosomes</article-title>. <source><italic toggle="yes">Mol Neurodegener</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>5</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13024-016-0143-y</pub-id><pub-id pub-id-type="pmid">28086931</pub-id></mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Saman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>NCY</given-names></string-name>, <string-name><surname>Inoyo</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer’s disease</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2014</year>;<volume>40</volume>(<issue>Suppl 1</issue>):<fpage>S47</fpage>–<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-132135</pub-id><pub-id pub-id-type="pmid">24718102</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Plouffe</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mohamed</surname>
<given-names>N-V</given-names></string-name>, <string-name><surname>Rivest-McGraw</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Hyperphosphorylation and cleavage at D421 enhance tau secretion</article-title>. <source><italic toggle="yes">PLoS One.</italic></source>
<year>2012</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e36873</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0036873</pub-id><pub-id pub-id-type="pmid">22615831</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Barthélemy</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>William</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Sleep deprivation affects tau phosphorylation in human cerebrospinal fluid</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2020</year>;<volume>87</volume>(<issue>5</issue>):<fpage>700</fpage>–<lpage>709</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.25702</pub-id><pub-id pub-id-type="pmid">32057125</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Obermeier</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Daneman</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ransohoff</surname>
<given-names>RM</given-names></string-name>. <article-title>Development, maintenance and disruption of the blood-brain barrier</article-title>. <source><italic toggle="yes">Nat Med</italic></source>. <year>2013</year>;<volume>19</volume>(<issue>12</issue>):<fpage>1584</fpage>–<lpage>1596</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.3407</pub-id><pub-id pub-id-type="pmid">24309662</pub-id></mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kress</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Dimitry</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Regulation of amyloid-beta dynamics and pathology by the circadian clock</article-title>. <source><italic toggle="yes">J Exp Med</italic></source>. <year>2018</year>;<volume>215</volume>(<issue>4</issue>):<fpage>1059</fpage>–<lpage>1068</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20172347</pub-id><pub-id pub-id-type="pmid">29382695</pub-id></mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scott Miners</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schulz</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Love</surname>
<given-names>S</given-names></string-name>. <article-title>Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer’s disease</article-title>. <source><italic toggle="yes">J Cereb Blood Flow Metab</italic></source>. <year>2018</year>;<volume>38</volume>(<issue>1</issue>):<fpage>103</fpage>–<lpage>115</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0271678X17690761</pub-id><pub-id pub-id-type="pmid">28151041</pub-id></mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yaming</surname>
<given-names>L</given-names></string-name>. <article-title>The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer’s disease</article-title>. <source><italic toggle="yes">Int J Neurosci</italic></source>. <year>2014</year>;<volume>124</volume>(<issue>2</issue>):<fpage>75</fpage>–<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.3109/00207454.2013.825258</pub-id><pub-id pub-id-type="pmid">23855502</pub-id></mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cai</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Qiao</surname>
<given-names>P-F</given-names></string-name>, <string-name><surname>Wan</surname>
<given-names>C-Q</given-names></string-name>, et al. <article-title>Role of blood-brain barrier in Alzheimer’s Disease</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2018</year>;<volume>63</volume>(<issue>4</issue>):<fpage>1223</fpage>–<lpage>1234</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-180098</pub-id><pub-id pub-id-type="pmid">29782323</pub-id></mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Amanda</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Anika</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Hartz</surname>
<given-names>MS</given-names></string-name>, et al. <article-title>New evidence for P-gp-mediated export of Amyloid-β PEPTIDES in molecular, blood-brain barrier and neuronal models</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2020</year>;<volume>22</volume>(<issue>1</issue>):<fpage>246</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms22010246</pub-id></mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ruyi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Huo</surname>
<given-names>Q</given-names></string-name>, et al. <article-title>Brain microvascular endothelial cell derived exosomes potently ameliorate cognitive dysfunction by enhancing the clearance of Aβ through up-regulation of P-gp in mouse model of AD</article-title>. <source><italic toggle="yes">Neurochem Res</italic></source>. <year>2020</year>;<volume>45</volume>(<issue>9</issue>):<fpage>2161</fpage>–<lpage>2172</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11064-020-03076-1</pub-id><pub-id pub-id-type="pmid">32583212</pub-id></mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Junyun</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hsuchou</surname>
<given-names>H</given-names></string-name>, <string-name><surname>He</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Sleep restriction impairs blood–brain barrier function</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2014</year>;<volume>34</volume>(<issue>44</issue>):<fpage>14697</fpage>–<lpage>14706</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2111-14.2014</pub-id><pub-id pub-id-type="pmid">25355222</pub-id></mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Khalyfa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gozal</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kheirandish-Gozal.</surname>
<given-names>L</given-names></string-name>. <article-title>Plasma extracellular vesicles in children with OSA disrupt blood-brain barrier integrity and endothelial cell wound healing in vitro</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2019</year>;<volume>20</volume>(<issue>24</issue>):<fpage>6233</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms20246233</pub-id></mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Khalyfa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kheirandish-Gozal</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Khalyfa</surname>
<given-names>AA</given-names></string-name>, et al. <article-title>Circulating plasma extracellular microvesicle MicroRNA cargo and endothelial dysfunction in children with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2016</year>;<volume>194</volume>(<issue>9</issue>):<fpage>1116</fpage>–<lpage>1126</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201602-0323OC</pub-id><pub-id pub-id-type="pmid">27163713</pub-id></mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Saliminejad</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Reza</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Khorshid</surname>
<given-names>K</given-names></string-name>, et al. <article-title>An overview of microRNAs: biology, functions, therapeutics, and analysis methods</article-title>. <source><italic toggle="yes">J Cell Physiol</italic></source>. <year>2019</year>;<volume>234</volume>(<issue>5</issue>):<fpage>5451</fpage>–<lpage>5465</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcp.27486</pub-id><pub-id pub-id-type="pmid">30471116</pub-id></mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Treiber</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Treiber</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Meister</surname>
<given-names>G</given-names></string-name>. <article-title>Regulation of microRNA biogenesis and its crosstalk with other cellular pathways</article-title>. <source><italic toggle="yes">Nat Rev Mol Cell Biol</italic></source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41580-018-0059-1</pub-id><pub-id pub-id-type="pmid">30228348</pub-id></mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Inoue</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ishii</surname>
<given-names>J</given-names></string-name>, et al. <article-title>MicroRNA feedback circuit in midbrain dopamine neurons</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2007</year>;<volume>317</volume>(<issue>5842</issue>):<fpage>1220</fpage>–<lpage>1224</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1140481</pub-id><pub-id pub-id-type="pmid">17761882</pub-id></mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Davis</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Cuellar</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Koch</surname>
<given-names>SM</given-names></string-name>, et al. <article-title>Conditional loss of dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2008</year>;<volume>28</volume>(<issue>17</issue>):<fpage>4322</fpage>–<lpage>4330</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4815-07.2008</pub-id><pub-id pub-id-type="pmid">18434510</pub-id></mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yanfeng</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from MicroRNA 133b-overexpressing multipotent mesenchymal stromal cells</article-title>. <source><italic toggle="yes">Cell Transplant</italic></source>. <year>2017</year>;<volume>26</volume>(<issue>2</issue>):<fpage>243</fpage>–<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.3727/096368916X693031</pub-id><pub-id pub-id-type="pmid">27677799</pub-id></mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Alex Mitsialis</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Aslam</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2012</year>;<volume>126</volume>(<issue>22</issue>):<fpage>2601</fpage>–<lpage>2611</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.114173</pub-id><pub-id pub-id-type="pmid">23114789</pub-id></mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rodriguez-Vieitez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>HM</given-names></string-name>. <article-title>Associations between APOE variants, Tau and α-Synuclein</article-title>. <source><italic toggle="yes">Adv Exp Med Biol.</italic></source>
<year>2019</year>;<volume>1184</volume>:<fpage>177</fpage>–<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-981-32-9358-8_15</pub-id><pub-id pub-id-type="pmid">32096038</pub-id></mixed-citation>
      </ref>
      <ref id="cit0077">
        <label>77.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kumar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hemachandra Reddy</surname>
<given-names>P</given-names></string-name>. <article-title>Are circulating microRNAs peripheral biomarkers for Alzheimer’s disease?</article-title>
<source><italic toggle="yes">Biochim Biophys Acta</italic></source>. <year>2016</year>;<volume>1862</volume>(<issue>9</issue>):<fpage>1617</fpage>–<lpage>1627</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbadis.2016.06.001</pub-id><pub-id pub-id-type="pmid">27264337</pub-id></mixed-citation>
      </ref>
      <ref id="cit0078">
        <label>78.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Samadian</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gholipour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hajiesmaeili</surname>
<given-names>M</given-names></string-name>, et al. <article-title>The eminent role of microRNAs in the pathogenesis of Alzheimer’s Disease</article-title>. <source><italic toggle="yes">Front Aging Neurosci</italic></source>. <year>2021</year>;<volume>13</volume>:<fpage>641080</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2021.641080</pub-id><pub-id pub-id-type="pmid">33790780</pub-id></mixed-citation>
      </ref>
      <ref id="cit0079">
        <label>79.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>L-H</given-names></string-name>, <string-name><surname>Ban</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>C-D</given-names></string-name>, et al. <article-title>Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation</article-title>. <source><italic toggle="yes">J Neurochem</italic></source>. <year>2015</year>;<volume>134</volume>(<issue>6</issue>):<fpage>1139</fpage>–<lpage>1151</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnc.13212</pub-id><pub-id pub-id-type="pmid">26118667</pub-id></mixed-citation>
      </ref>
      <ref id="cit0080">
        <label>80.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brites</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fernandes</surname>
<given-names>A</given-names></string-name>. <article-title>Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation</article-title>. <source><italic toggle="yes">Front Cell Neurosci</italic></source>. <year>2015</year>;<volume>9</volume>:<fpage>476</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2015.00476</pub-id><pub-id pub-id-type="pmid">26733805</pub-id></mixed-citation>
      </ref>
      <ref id="cit0081">
        <label>81.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Le</surname>
<given-names>W</given-names></string-name>. <article-title>Differential roles of M1 and M2 microglia in neurodegenerative diseases</article-title>. <source><italic toggle="yes">Mol Neurobiol</italic></source>. <year>2016</year>;<volume>53</volume>(<issue>2</issue>):<fpage>1181</fpage>–<lpage>1194</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12035-014-9070-5</pub-id><pub-id pub-id-type="pmid">25598354</pub-id></mixed-citation>
      </ref>
      <ref id="cit0082">
        <label>82.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ransohoff</surname>
<given-names>RM</given-names></string-name>. <article-title>A polarizing question: do M1 and M2 microglia exist?</article-title>
<source><italic toggle="yes">Nat Neurosci</italic></source>. <year>2016</year>;<volume>19</volume>(<issue>8</issue>):<fpage>987</fpage>–<lpage>991</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4338</pub-id><pub-id pub-id-type="pmid">27459405</pub-id></mixed-citation>
      </ref>
      <ref id="cit0083">
        <label>83.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Krstic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Knuesel</surname>
<given-names>I</given-names></string-name>. <article-title>Deciphering the mechanism underlying late-onset Alzheimer disease</article-title>. <source><italic toggle="yes">Nat Rev Neurol</italic></source>. <year>2013</year>;<volume>9</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>34</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrneurol.2012.236</pub-id><pub-id pub-id-type="pmid">23183882</pub-id></mixed-citation>
      </ref>
      <ref id="cit0084">
        <label>84.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Giacobbo</surname>
<given-names>BL</given-names></string-name>, <string-name><surname>Doorduin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Klein</surname>
<given-names>HC</given-names></string-name>, et al. <article-title>Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation</article-title>. <source><italic toggle="yes">Mol Neurobiol</italic></source>. <year>2019</year>;<volume>56</volume>(<issue>5</issue>):<fpage>3295</fpage>–<lpage>3312</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12035-018-1283-6</pub-id><pub-id pub-id-type="pmid">30117106</pub-id></mixed-citation>
      </ref>
      <ref id="cit0085">
        <label>85.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wadhwa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Prabhakar</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation</article-title>. <source><italic toggle="yes">J Neuroinflammation</italic></source>. <year>2017</year>;<volume>14</volume>(<issue>1</issue>):<fpage>222</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12974-017-0998-z</pub-id><pub-id pub-id-type="pmid">29141671</pub-id></mixed-citation>
      </ref>
      <ref id="cit0086">
        <label>86.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>Y-C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ying</surname>
<given-names>S</given-names></string-name>, et al. <article-title>MicroRNA-26b regulates the microglial inflammatory response in hypoxia/ischemia and affects the development of vascular cognitive impairment</article-title>. <source><italic toggle="yes">Front Cell Neurosci</italic></source>. <year>2018</year>;<volume>12</volume>:<fpage>154</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2018.00154</pub-id><pub-id pub-id-type="pmid">29937716</pub-id></mixed-citation>
      </ref>
      <ref id="cit0087">
        <label>87.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mosakhani</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Sarhadi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Panula</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Narcolepsy patients’ blood-based miRNA expression profiling: miRNAexpression differences with Pandemrix vaccination</article-title>. <source><italic toggle="yes">Acta Neurol Scand</italic></source>. <year>2017</year>;<volume>136</volume>(<issue>5</issue>):<fpage>462</fpage>–<lpage>469</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ane.12749</pub-id><pub-id pub-id-type="pmid">28251619</pub-id></mixed-citation>
      </ref>
      <ref id="cit0088">
        <label>88.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mishra</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>Tyagi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kundu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tyagi</surname>
<given-names>SC</given-names></string-name>. <article-title>MicroRNAs are involved in homocysteine-induced cardiac remodeling</article-title>. <source><italic toggle="yes">Cell Biochem Biophys</italic></source>. <year>2009</year>;<volume>55</volume>(<issue>3</issue>):<fpage>153</fpage>–<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12013-009-9063-6</pub-id><pub-id pub-id-type="pmid">19669742</pub-id></mixed-citation>
      </ref>
      <ref id="cit0089">
        <label>89.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>J-H</given-names></string-name>, <string-name><surname>Kwon</surname>
<given-names>O-B</given-names></string-name>, et al. <article-title>An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2012</year>;<volume>32</volume>(<issue>16</issue>):<fpage>5678</fpage>–<lpage>5687</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6471-11.2012</pub-id><pub-id pub-id-type="pmid">22514329</pub-id></mixed-citation>
      </ref>
      <ref id="cit0090">
        <label>90.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ni</surname>
<given-names>Junjun</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Meng</surname>
<given-names>J</given-names></string-name>, et al. <article-title>An impaired intrinsic microglial clocksystem induces neuroinflammatory alterations in the early stage of amyloid precursor protein knock-in mouse brain</article-title>. <source><italic toggle="yes">J Neuroinflammation</italic></source>. <year>2019</year>;<volume>16</volume>(<issue>1</issue>):<fpage>173</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12974-019-1562-9</pub-id><pub-id pub-id-type="pmid">31470863</pub-id></mixed-citation>
      </ref>
      <ref id="cit0091">
        <label>91.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rahmani</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rezaei</surname>
<given-names>N</given-names></string-name>. <article-title>Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis</article-title>. <source><italic toggle="yes">Expert Rev Clin Immunol</italic></source>. <year>2016</year>;<volume>12</volume>(<issue>12</issue>):<fpage>1289</fpage>–<lpage>1298</lpage>. doi:<pub-id pub-id-type="doi">10.1080/1744666X.2016.1204232</pub-id><pub-id pub-id-type="pmid">27359083</pub-id></mixed-citation>
      </ref>
      <ref id="cit0092">
        <label>92.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Surbhi</surname></string-name>, <string-name><surname>Borniger</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Russart</surname>
<given-names>KLG</given-names></string-name>, et al. <article-title>miR-155 deletion modulates lipopolysaccharide-induced sleep in female mice</article-title>. <source><italic toggle="yes">Chronobiol Int</italic></source>. <year>2019</year>;<volume>36</volume>(<issue>2</issue>):<fpage>188</fpage>–<lpage>202</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07420528.2018.1525617</pub-id><pub-id pub-id-type="pmid">30299169</pub-id></mixed-citation>
      </ref>
      <ref id="cit0093">
        <label>93.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nakano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kubota</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kobayashi</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Bone marrow‑derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA‑146a in hippocampus</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>10772</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-020-67460-1</pub-id><pub-id pub-id-type="pmid">32612165</pub-id></mixed-citation>
      </ref>
      <ref id="cit0094">
        <label>94.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>Y-C</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>P-Y</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>M-C</given-names></string-name>, et al. <article-title>miR-21-5p under-expression in patients with obstructive sleep apnea modulates intermittent hypoxia with re-oxygenation-induced-cell apoptosis and cytotoxicity by targeting pro-inflammatory TNF-α-TLR4 signaling</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>3</issue>):<fpage>999</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms21030999</pub-id></mixed-citation>
      </ref>
      <ref id="cit0095">
        <label>95.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Du</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>J</given-names></string-name>. <article-title>Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 axis inhibits the hippocampal inflammatory response in T2DM with OSA</article-title>. <source><italic toggle="yes">Front Cell Neurosci.</italic></source>
<year>2020</year>;<volume>14</volume>:<fpage>97</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2020.00097</pub-id><pub-id pub-id-type="pmid">32477065</pub-id></mixed-citation>
      </ref>
      <ref id="cit0096">
        <label>96.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Qian</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Min</surname>
<given-names>G</given-names></string-name>, et al. <article-title>MicroRNA-181c ameliorates cognitive impairment induced by chronic cerebral hypoperfusion in rats</article-title>. <source><italic toggle="yes">Mol Neurobiol</italic></source>. <year>2017</year>;<volume>54</volume>(<issue>10</issue>):<fpage>8370</fpage>–<lpage>8385</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12035-016-0268-6</pub-id><pub-id pub-id-type="pmid">27933582</pub-id></mixed-citation>
      </ref>
      <ref id="cit0097">
        <label>97.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rosa</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Fahnestock</surname>
<given-names>M</given-names></string-name>. <article-title>CREB expression mediates amyloid β-induced basal BDNF downregulation</article-title>. <source><italic toggle="yes">Neurobiol Aging</italic></source>. <year>2015</year>;<volume>36</volume>(<issue>8</issue>):<fpage>2406</fpage>–<lpage>2413</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.04.014</pub-id><pub-id pub-id-type="pmid">26025137</pub-id></mixed-citation>
      </ref>
      <ref id="cit0098">
        <label>98.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Salta</surname>
<given-names>E</given-names></string-name>, <string-name><surname>De Strooper</surname>
<given-names>B</given-names></string-name>. <article-title>microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer’s disease</article-title>. <source><italic toggle="yes">FASEB J</italic></source>. <year>2017</year>;<volume>31</volume>(<issue>2</issue>):<fpage>424</fpage>–<lpage>433</lpage>. doi:<pub-id pub-id-type="doi">10.1096/fj.201601308</pub-id><pub-id pub-id-type="pmid">28148775</pub-id></mixed-citation>
      </ref>
      <ref id="cit0099">
        <label>99.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ang-Di</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Li-Li</surname>
<given-names>J</given-names></string-name>, et al. <article-title>miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q</article-title>. <source><italic toggle="yes">Eur J Histochem</italic></source>. <year>2019</year>;<volume>63</volume>(<issue>2</issue>):<fpage>3008</fpage>. doi:<pub-id pub-id-type="doi">10.4081/ejh.2019.3008</pub-id></mixed-citation>
      </ref>
      <ref id="cit0100">
        <label>100.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fiore</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Khudayberdiev</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Christensen</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels</article-title>. <source><italic toggle="yes">EMBO J</italic></source>. <year>2009</year>;<volume>28</volume>(<issue>6</issue>):<fpage>697</fpage>–<lpage>710</lpage>. doi:<pub-id pub-id-type="doi">10.1038/emboj.2009.10</pub-id><pub-id pub-id-type="pmid">19197241</pub-id></mixed-citation>
      </ref>
      <ref id="cit0101">
        <label>101.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yamakuchi</surname>
<given-names>M</given-names></string-name>. <article-title>MicroRNA regulation of SIRT1</article-title>. <source><italic toggle="yes">Front Physiol.</italic></source>
<year>2012</year>;<volume>3</volume>:<fpage>68</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2012.00068</pub-id><pub-id pub-id-type="pmid">22479251</pub-id></mixed-citation>
      </ref>
      <ref id="cit0102">
        <label>102.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riancho</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Luis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vázquez-Higuera</surname></string-name>, et al. <article-title>MicroRNA profile in patients with Alzheimer’s Disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2017</year>;<volume>57</volume>(<issue>2</issue>):<fpage>483</fpage>–<lpage>491</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-161179</pub-id><pub-id pub-id-type="pmid">28269782</pub-id></mixed-citation>
      </ref>
      <ref id="cit0103">
        <label>103.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yunjun</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, et al. <article-title>HucMSCs-derived miR-206-knockdown exosomes contribute to neuroprotection in subarachnoid hemorrhage induced early brain injury by targeting BDNF</article-title>. <source><italic toggle="yes">Neuroscience.</italic></source>
<year>2019</year>;<volume>417</volume>:<fpage>11</fpage>–<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2019.07.051</pub-id><pub-id pub-id-type="pmid">31400488</pub-id></mixed-citation>
      </ref>
      <ref id="cit0104">
        <label>104.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Daulatzai</surname>
<given-names>MA</given-names></string-name>. <article-title>Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s disease</article-title>. <source><italic toggle="yes">J Neurosci Res</italic></source>. <year>2017</year>;<volume>95</volume>(<issue>4</issue>):<fpage>943</fpage>–<lpage>972</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jnr.23777</pub-id><pub-id pub-id-type="pmid">27350397</pub-id></mixed-citation>
      </ref>
      <ref id="cit0105">
        <label>105.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brayet</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Petit</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Baril</surname>
<given-names>A-A</given-names></string-name>, et al. <article-title>Brain perfusion during rapid -eye-movement sleep successfully identifies amnestic mild cognitive impairment</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2017</year>;<volume>34</volume>:<fpage>134</fpage>–<lpage>140</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2017.01.025</pub-id><pub-id pub-id-type="pmid">28522082</pub-id></mixed-citation>
      </ref>
      <ref id="cit0106">
        <label>106.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hampel</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Vassar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>De Strooper</surname>
<given-names>B</given-names></string-name>. <article-title>The β-Secretase BACE1 in Alzheimer’s disease</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2021</year>;<volume>89</volume>(<issue>8</issue>):<fpage>745</fpage>–<lpage>756</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2020.02.001</pub-id><pub-id pub-id-type="pmid">32223911</pub-id></mixed-citation>
      </ref>
      <ref id="cit0107">
        <label>107.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>C</given-names></string-name>, et al. <article-title>miR-124 regulates the expression of BACE1 in the hippocampus under chronic cerebral hypoperfusion</article-title>. <source><italic toggle="yes">Mol Neurobiol</italic></source>. <year>2017</year>;<volume>54</volume>(<issue>4</issue>):<fpage>2498</fpage>–<lpage>2506</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12035-016-9845-y</pub-id><pub-id pub-id-type="pmid">26984601</pub-id></mixed-citation>
      </ref>
      <ref id="cit0108">
        <label>108.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>JA-H</given-names></string-name>, <string-name><surname>Che</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>R</given-names></string-name>, et al. <article-title>MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2013</year>;<volume>33</volume>(<issue>9</issue>):<fpage>3989</fpage>–<lpage>4001</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1997-12.2013</pub-id><pub-id pub-id-type="pmid">23447608</pub-id></mixed-citation>
      </ref>
      <ref id="cit0109">
        <label>109.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma</article-title>. <source><italic toggle="yes">Oncotarget</italic></source>. <year>2016</year>;<volume>7</volume>(<issue>17</issue>):<fpage>24383</fpage>–<lpage>24401</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.8328</pub-id><pub-id pub-id-type="pmid">27027434</pub-id></mixed-citation>
      </ref>
      <ref id="cit0110">
        <label>110.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Maiese</surname>
<given-names>K</given-names></string-name>. <article-title>Moving to the rhythm with Clock (Circadian) genes, autophagy, mTOR, and SIRT1 in degenerative disease and cancer</article-title>. <source><italic toggle="yes">Curr. Neurovasc Res</italic></source>. <year>2017</year>;<volume>14</volume>(<issue>3</issue>):<fpage>299</fpage>–<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1567202614666170718092010</pub-id><pub-id pub-id-type="pmid">28721811</pub-id></mixed-citation>
      </ref>
      <ref id="cit0111">
        <label>111.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Intermittent hypoxia caused cognitive dysfunction relate to miRNAs dysregulation in hippocampus</article-title>. <source><italic toggle="yes">Behav Brain Res</italic></source>. <year>2017</year>;<volume>335</volume>:<fpage>80</fpage>–<lpage>87</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2017.06.025</pub-id><pub-id pub-id-type="pmid">28647595</pub-id></mixed-citation>
      </ref>
      <ref id="cit0112">
        <label>112.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>H-Z</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>-F-F</given-names></string-name>, et al. <article-title>Global microRNA expression profiling reveals differential expression of target genes in 6-hydroxydopamine-injured MN9D cells</article-title>. <source><italic toggle="yes">Neuromolecular Med</italic></source>. <year>2013</year>;<volume>15</volume>(<issue>3</issue>):<fpage>593</fpage>–<lpage>604</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12017-013-8244-z</pub-id><pub-id pub-id-type="pmid">23846856</pub-id></mixed-citation>
      </ref>
      <ref id="cit0113">
        <label>113.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ren</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Qiuyun</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Potential contribution of microRNA-125b targeting p38MAPK to relieving intermittent hypoxia-induced dementia of rat models</article-title>. <source><italic toggle="yes">J Clin Neurosci</italic></source>. <year>2019</year>;<volume>64</volume>:<fpage>234</fpage>–<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jocn.2019.03.002</pub-id><pub-id pub-id-type="pmid">31000329</pub-id></mixed-citation>
      </ref>
      <ref id="cit0114">
        <label>114.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z-F</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Protective effects of microRNA-330 on amyloid β-protein production, oxidative stress, and mitochondrial dysfunction in Alzheimer’s disease by targeting VAV1 via the MAPK signaling pathway</article-title>. <source><italic toggle="yes">J Cell Biochem</italic></source>. <year>2018</year>;<volume>119</volume>(<issue>7</issue>):<fpage>5437</fpage>–<lpage>5448</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcb.26700</pub-id><pub-id pub-id-type="pmid">29369410</pub-id></mixed-citation>
      </ref>
      <ref id="cit0115">
        <label>115.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jinlei</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ogrodnik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kolachalama</surname>
<given-names>VB</given-names></string-name>, et al. <article-title>Assessment of the mid-life demographic and lifestyle risk factors of dementia using data from the Framingham heart study offspring cohort</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2018</year>;<volume>63</volume>(<issue>3</issue>):<fpage>1119</fpage>–<lpage>1127</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-170917</pub-id><pub-id pub-id-type="pmid">29710704</pub-id></mixed-citation>
      </ref>
      <ref id="cit0116">
        <label>116.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dehghani</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rahmani</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rezaei</surname>
<given-names>N</given-names></string-name>. <article-title>MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms</article-title>. <source><italic toggle="yes">Rev Neurosci</italic></source>. <year>2018</year>;<volume>29</volume>(<issue>2</issue>):<fpage>161</fpage>–<lpage>182</lpage>. doi:<pub-id pub-id-type="doi">10.1515/revneuro-2017-0042</pub-id><pub-id pub-id-type="pmid">28941357</pub-id></mixed-citation>
      </ref>
      <ref id="cit0117">
        <label>117.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Slota</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Booth</surname>
<given-names>SA</given-names></string-name>. <article-title>MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications</article-title>. <source><italic toggle="yes">Noncoding RNA</italic></source>. <year>2019</year>;<volume>5</volume>(<issue>2</issue>):<fpage>35</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ncrna5020035</pub-id></mixed-citation>
      </ref>
      <ref id="cit0118">
        <label>118.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cui</surname>
<given-names>G-H</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>H-D</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>L</given-names></string-name>, et al. <article-title>RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease</article-title>. <source><italic toggle="yes">Immun Ageing.</italic></source>
<year>2019</year>;<volume>16</volume>:<fpage>10</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12979-019-0150-2</pub-id><pub-id pub-id-type="pmid">31114624</pub-id></mixed-citation>
      </ref>
      <ref id="cit0119">
        <label>119.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Duan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Limei</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Exosome-mediated delivery of gene vectors for gene therapy</article-title>. <source><italic toggle="yes">Nanoscale</italic></source>. <year>2021</year>;<volume>13</volume>(<issue>3</issue>):<fpage>1387</fpage>–<lpage>1397</lpage>. doi:<pub-id pub-id-type="doi">10.1039/d0nr07622h</pub-id><pub-id pub-id-type="pmid">33350419</pub-id></mixed-citation>
      </ref>
      <ref id="cit0120">
        <label>120.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fowler</surname>
<given-names>CD</given-names></string-name>. <article-title>NeuroEVs:: Characterizing extracellular vesicles generated in the neural domain</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2019</year>;<volume>39</volume>(<issue>47</issue>):<fpage>9262</fpage>–<lpage>9268</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0146-18.2019</pub-id><pub-id pub-id-type="pmid">31748281</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
